Lipoprotein storage disorders emerge as a heterogeneous group of rare metabolic diseases. These conditions are characterized by the storage of abnormal lipoproteins, primarily within the cells, leading to a spectrum of clinical manifestations. The underlying mechanisms involve defects in the processing of apolipoproteins or enzymes involved in lipi